(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Sorrento Therapeutics, Orange, and Global X AI.

Rank	Financial Asset	Price	Premarket Change	Updated (EST)
1	Sorrento Therapeutics (SRNE)	0.18	5.99%	2023-02-16 07:29:24
2	Orange (ORAN)	11.32	5.99%	2023-02-16 07:24:53
3	Global X AI (AIQ)	24.99	4.34%	2023-02-16 04:07:34
4	FuboTV (FUBO)	2.49	3.32%	2023-02-16 07:07:42
5	Riot Blockchain (RIOT)	6.78	1.8%	2023-02-16 07:32:55
6	Regions Financial Corporation (RF)	24.26	1.51%	2023-02-16 04:42:37
7	Banco Santander (SAN)	3.76	1.35%	2023-02-16 07:19:29
8	NeuroMetrix (NURO)	1.76	1.2%	2023-02-16 04:07:16
9	Intercontinental Exchange (ICE)	109.90	1.16%	2023-02-16 04:14:52
10	Banco Bradesco (BBD)	2.70	1.12%	2023-02-16 06:55:18

The three biggest losers today are Upwork, Xenetic Biosciences, and SK Telecom.

Rank	Financial Asset	Price	Premarket Change	Updated (EST)
1	Upwork (UPWK)	12.83	-7.96%	2023-02-16 07:33:45
2	Xenetic Biosciences (XBIO)	0.56	-3.4%	2023-02-16 07:33:55
3	SK Telecom (SKM)	19.54	-3.27%	2023-02-16 07:25:38
4	Aspen Group (ASPU)	0.21	-1.32%	2023-02-16 04:16:59
5	FuelCell Energy (FCEL)	3.79	-1.3%	2023-02-16 07:25:12
6	Transocean (RIG)	7.55	-0.79%	2023-02-16 07:33:58
7	Kodak (KODK)	3.78	-0.79%	2023-02-16 04:15:46
8	Amicus Therapeutics (FOLD)	13.01	-0.76%	2023-02-16 05:12:54
9	KKR & Co. (KKR)	58.46	-0.75%	2023-02-16 04:41:10
10	Geo Group (GEO)	9.85	-0.51%	2023-02-16 07:13:59

Premarket Winners today

1. Sorrento Therapeutics (SRNE) – Premarket: 5.99%

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.

NASDAQ ended the session with Sorrento Therapeutics sliding 11.85% to $0.17 on Thursday, after three consecutive sessions in a row of losses. NASDAQ rose 0.92% to $12,070.59, after three sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -326.72%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 56.1% and 35%, respectively.

More news about Sorrento Therapeutics.

2. Orange (ORAN) – Premarket: 5.99%

Orange S.A. provides various fixed telephony and mobile telecommunications, data transmission, and other value-added services to customers, businesses, and other telecommunications operators in France and internationally. It operates through France; Spain and Other European Countries; The Africa and Middle East; Enterprise; International Carriers & Shared Services; and Mobile Financial Services segments. The company offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages. It also sells mobile handsets, mobile terminals, broadband equipment, connected devices, and accessories. In addition, the company provides IT and integration services comprising unified communication and collaboration services, such as LAN and telephony, consultancy, integration, and project management; hosting and infrastructure services, including cloud computing; customer relations management and other applications services; security services; and video conferencing, as well as sells related equipment. Further, it offers national and international roaming services; online advertising services; and mobile virtual network operators, network sharing, and mobile financial services, as well as sells equipment to external distributors and brokers. The company markets its products and services under the Orange brand. The company was formerly known as France Telecom and changed its name to Orange S.A. in July 2013. Orange S.A. was founded in 1990 and is headquartered in Issy-les-Moulineaux, France.

NYSE ended the session with Orange sliding 0% to $10.68 on Thursday, after two consecutive sessions in a row of losses. NYSE slid 0.06% to $16,016.09, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Orange has a trailing twelve months EPS of $2.06.

PE Ratio

Orange has a trailing twelve months price to earnings ratio of 5.19. Meaning, the purchaser of the share is investing $5.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.23%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 2, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 8.14%.

Moving Average

Orange’s worth is higher than its 50-day moving average of $10.08 and above its 200-day moving average of $10.59.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Orange’s stock is considered to be oversold (<=20).

Volatility

Orange’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.52%, a negative 0.13%, and a positive 0.93%.

Orange’s highest amplitude of average volatility was 0.82% (last week), 0.91% (last month), and 0.93% (last quarter).

More news about Orange.

3. Global X AI (AIQ) – Premarket: 4.34%

NASDAQ ended the session with Global X AI jumping 1.1% to $23.95 on Thursday while NASDAQ rose 0.92% to $12,070.59.

Earnings Per Share

As for profitability, Global X AI has a trailing twelve months EPS of $0.36.

More news about Global X AI.

4. FuboTV (FUBO) – Premarket: 3.32%

fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.

NYSE ended the session with FuboTV jumping 11.86% to $2.41 on Thursday, after four successive sessions in a row of gains. NYSE slid 0.06% to $16,016.09, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.53%.

Yearly Top and Bottom Value

FuboTV’s stock is valued at $2.41 at 07:34 EST, way under its 52-week high of $35.10 and above its 52-week low of $2.32.

Moving Average

FuboTV’s value is way under its 50-day moving average of $3.74 and way below its 200-day moving average of $6.71.

More news about FuboTV.

5. Riot Blockchain (RIOT) – Premarket: 1.8%

Riot Blockchain, Inc., together with its subsidiaries, focuses on bitcoin mining operations in North America. It operates through Bitcoin Mining, Data Center Hosting, and Electrical Products and Engineering segments. As of December 31, 2021, it operated approximately 30,907 miners. Riot Blockchain, Inc. was incorporated in 2000 and is headquartered in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain rising 12.97% to $6.66 on Thursday, after four consecutive sessions in a row of gains. NASDAQ jumped 0.92% to $12,070.59, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.5%.

Volatility

Riot Blockchain’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.01%, a negative 0.15%, and a positive 4.85%.

Riot Blockchain’s highest amplitude of average volatility was 6.01% (last week), 5.53% (last month), and 4.85% (last quarter).

Moving Average

Riot Blockchain’s worth is way above its 50-day moving average of $4.85 and above its 200-day moving average of $6.40.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Riot Blockchain’s stock is considered to be oversold (<=20).

More news about Riot Blockchain.

6. Regions Financial Corporation (RF) – Premarket: 1.51%

Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers. It operates through three segments: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending; equipment lease financing; deposit products; and securities underwriting and placement, loan syndication and placement, foreign exchange, derivatives, merger and acquisition, and other advisory services. It serves corporate, middle market, and commercial real estate developers and investors. The Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, consumer credit cards, and other consumer loans, as well as deposits. The Wealth Management segment offers credit related products, and retirement and savings solutions; and trust and investment management, asset management, and estate planning services to individuals, businesses, governmental institutions, and non-profit entities. The company also provides investment and insurance products; low-income housing tax credit corporate fund syndication services; and other specialty financing services. As of March 01, 2022, it operated through a network of 1,300 banking offices and 2,000 automated teller machines across the South, Midwest, and Texas. Regions Financial Corporation was founded in 1971 and is headquartered in Birmingham, Alabama.

NYSE ended the session with Regions Financial Corporation rising 0.19% to $23.90 on Thursday, after two sequential sessions in a row of gains. NYSE dropped 0.06% to $16,016.09, after two sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Regions Financial Corporation has a trailing twelve months EPS of $1.52.

PE Ratio

Regions Financial Corporation has a trailing twelve months price to earnings ratio of 15.71. Meaning, the purchaser of the share is investing $15.71 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.82%.

Moving Average

Regions Financial Corporation’s value is higher than its 50-day moving average of $22.09 and way higher than its 200-day moving average of $21.21.

Volume

Today’s last reported volume for Regions Financial Corporation is 4528740 which is 35.7% below its average volume of 7043660.

Yearly Top and Bottom Value

Regions Financial Corporation’s stock is valued at $23.90 at 07:34 EST, below its 52-week high of $25.57 and way above its 52-week low of $18.01.

Sales Growth

Regions Financial Corporation’s sales growth is 17.1% for the current quarter and 18.8% for the next.

More news about Regions Financial Corporation.

7. Banco Santander (SAN) – Premarket: 1.35%

Banco Santander, S.A. provides various retail and commercial banking products and services to individuals, small and medium-sized enterprises, and large companies worldwide. It offers demand and time deposits, and current and savings accounts; mortgages, consumer finance, syndicated corporate loans, structured financing, cash management, export and agency finance, trade and working capital solutions, and corporate finance; and insurance products. The company also provides cash, asset, and wealth management; and private banking services. In addition, it is involved in the corporate banking; treasury, risk hedging, foreign trade, confirming, custody, and investment banking activities. The company operates through a network of 9,879 branches. The company was formerly known as Banco Santander Central Hispano S.A. and changed its name to Banco Santander, S.A. in June 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.

NYSE ended the session with Banco Santander falling 1.2% to $3.71 on Thursday while NYSE slid 0.06% to $16,016.09.

Earnings Per Share

As for profitability, Banco Santander has a trailing twelve months EPS of $-0.668.

Yearly Top and Bottom Value

Banco Santander’s stock is valued at $3.71 at 07:34 EST, under its 52-week high of $3.93 and way above its 52-week low of $2.26.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Oct 30, 2022, the estimated forward annual dividend rate is 0.11 and the estimated forward annual dividend yield is 4.09%.

More news about Banco Santander.

8. NeuroMetrix (NURO) – Premarket: 1.2%

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix sliding 2.79% to $1.74 on Thursday while NASDAQ rose 0.92% to $12,070.59.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.47%.

More news about NeuroMetrix.

9. Intercontinental Exchange (ICE) – Premarket: 1.16%

Intercontinental Exchange, Inc., together with its subsidiaries, operates regulated exchanges, clearing houses, and listings venues for commodity, financial, fixed income, and equity markets in the United States, the United Kingdom, the European Union, Singapore, Israel, and Canada. It operates through three segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The company operates marketplaces for listing, trading, and clearing an array of derivatives contracts and financial securities, such as commodities, interest rates, foreign exchange, and equities, as well as corporate and exchange-traded funds; trading venues, including 13 regulated exchanges and 6 clearing houses; and offers futures and options products for energy, agricultural and metals, financial, cash equities and equity, over-the-counter, and other markets, as well as listings and data and connectivity services. It also provides fixed income data and analytic, fixed income execution, CDS clearing, and other multi-asset class data and network services. In addition, the company offers proprietary and comprehensive mortgage origination platform, which serves residential mortgage loans; closing solutions that provides customers connectivity to the mortgage supply chain and facilitates the secure exchange of information; data and analytics services; and Data as a Service for lenders to access data and origination information. Intercontinental Exchange, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.

NYSE ended the session with Intercontinental Exchange jumping 0.22% to $108.64 on Thursday, following the last session’s upward trend. NYSE dropped 0.06% to $16,016.09, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Intercontinental Exchange has a trailing twelve months EPS of $3.74.

PE Ratio

Intercontinental Exchange has a trailing twelve months price to earnings ratio of 29.02. Meaning, the purchaser of the share is investing $29.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.43%.

Sales Growth

Intercontinental Exchange’s sales growth for the next quarter is negative 0.8%.

More news about Intercontinental Exchange.

10. Banco Bradesco (BBD) – Premarket: 1.12%

Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil. Banco Bradesco S.A. is a subsidiary of Cidade de Deus – Companhia Comercial de Participações.

NYSE ended the session with Banco Bradesco rising 3.89% to $2.67 on Thursday, following the last session’s upward trend. NYSE fell 0.06% to $16,016.09, after two sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.299.

PE Ratio

Banco Bradesco has a trailing twelve months price to earnings ratio of 8.93. Meaning, the purchaser of the share is investing $8.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.4%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Nov 2, 2022, the estimated forward annual dividend rate is 0.11 and the estimated forward annual dividend yield is 3.16%.

Volume

Today’s last reported volume for Banco Bradesco is 38373800 which is 1.16% below its average volume of 38827800.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Bradesco’s stock is considered to be oversold (<=20).

Volatility

Banco Bradesco’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.16%, a negative 0.49%, and a positive 2.86%.

Banco Bradesco’s highest amplitude of average volatility was 4.44% (last week), 2.98% (last month), and 2.86% (last quarter).

More news about Banco Bradesco.

Premarket Losers Today

1. Upwork (UPWK) – Premarket: -7.96%

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including sales and marketing, customer service, data science and analytics, design and creative, web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Enterprise, and Upwork Payroll, as well as managed and internet escrow agency services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Upwork jumping 5.81% to $13.94 on Thursday while NASDAQ jumped 0.92% to $12,070.59.

Earnings Per Share

As for profitability, Upwork has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.82%.

Moving Average

Upwork’s value is way above its 50-day moving average of $11.70 and way under its 200-day moving average of $16.29.

Volume

Today’s last reported volume for Upwork is 2584440 which is 111.38% above its average volume of 1222600.

More news about Upwork.

2. Xenetic Biosciences (XBIO) – Premarket: -3.4%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 1.53% to $0.58 on Thursday while NASDAQ rose 0.92% to $12,070.59.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.34%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 38.5% and a negative 46.2%, respectively.

Volume

Today’s last reported volume for Xenetic Biosciences is 10961 which is 85.32% below its average volume of 74681.

Sales Growth

Xenetic Biosciences’s sales growth for the next quarter is negative 27.9%.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.49%, a positive 2.28%, and a positive 5.37%.

Xenetic Biosciences’s highest amplitude of average volatility was 3.46% (last week), 5.95% (last month), and 5.37% (last quarter).

More news about Xenetic Biosciences.

3. SK Telecom (SKM) – Premarket: -3.27%

SK Telecom Co., Ltd. provides wireless telecommunication services in South Korea. The company operates through three segments: Cellular Services, Fixed-Line Telecommunications Services, and Other Businesses. The Cellular Services segment offers wireless voice and data transmission, Internet of Things solutions, platform, cloud, smart factory solutions, subscription, and metaverse platform-based services, as well as sells wireless devices. The Fixed-Line Telecommunications Services segment provides fixed-line telephone services; broadband Internet services; media platform services, such as Internet protocol TV and cable TV; and business communications services. The Other Businesses segment offers television shopping services under the T-commerce brand, as well as portal services. In addition, it provides call center management, base station maintenance, information gathering and consulting, system software development and supply, quantum information and communications, data base and internet website, and digital contents sourcing services; manufactures and sells e-book; sells contents and mastering quality sound album; sells and trades in anti-theft and surveillance devices; and operates information and communications facilities. As of December 31, 2021, the company had 3.6 million fixed-line telephone and 31.9 million wireless subscribers. SK Telecom Company Limited was incorporated in 1984 and is headquartered in Seoul, South Korea.

NYSE ended the session with SK Telecom dropping 4.4% to $20.20 on Thursday while NYSE fell 0.06% to $16,016.09.

Earnings Per Share

As for profitability, SK Telecom has a trailing twelve months EPS of $2.03.

PE Ratio

SK Telecom has a trailing twelve months price to earnings ratio of 9.97. Meaning, the purchaser of the share is investing $9.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.95%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 1.84 and the estimated forward annual dividend yield is 9.41%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4%, now sitting on 17.08T for the twelve trailing months.

More news about SK Telecom.

4. Aspen Group (ASPU) – Premarket: -1.32%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group falling 2.16% to $0.21 on Thursday while NASDAQ rose 0.92% to $12,070.59.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.35%.

More news about Aspen Group.

5. FuelCell Energy (FCEL) – Premarket: -1.3%

FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.

NASDAQ ended the session with FuelCell Energy rising 9.89% to $3.84 on Thursday while NASDAQ rose 0.92% to $12,070.59.

Earnings Per Share

As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.399.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.17%.

Moving Average

FuelCell Energy’s worth is way above its 50-day moving average of $3.30 and above its 200-day moving average of $3.62.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FuelCell Energy’s stock is considered to be oversold (<=20).

Volatility

FuelCell Energy’s last week, last month’s, and last quarter’s current intraday variation average was 2.43%, 0.83%, and 4.50%.

FuelCell Energy’s highest amplitude of average volatility was 3.45% (last week), 5.02% (last month), and 4.50% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 40% and positive 12.5% for the next.

More news about FuelCell Energy.

6. Transocean (RIG) – Premarket: -0.79%

Transocean Ltd., together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide. It contracts its mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells. As of February 14, 2022, the company had partial ownership interests in and operated a fleet of 37 mobile offshore drilling units, including 27 ultra-deep water and 10 harsh environment floaters. It serves integrated energy companies, government-owned or government-controlled oil companies, and other independent energy companies. The company was founded in 1926 and is based in Steinhausen, Switzerland.

NYSE ended the session with Transocean jumping 1% to $7.61 on Thursday while NYSE slid 0.06% to $16,016.09.

Earnings Per Share

As for profitability, Transocean has a trailing twelve months EPS of $-0.92.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.72%.

Yearly Top and Bottom Value

Transocean’s stock is valued at $7.61 at 07:34 EST, higher than its 52-week high of $7.60.

Sales Growth

Transocean’s sales growth is 6.5% for the ongoing quarter and 5.3% for the next.

Volatility

Transocean’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.10%, a positive 1.37%, and a positive 3.24%.

Transocean’s highest amplitude of average volatility was 1.26% (last week), 2.83% (last month), and 3.24% (last quarter).

More news about Transocean.

7. Kodak (KODK) – Premarket: -0.79%

Eastman Kodak Company provides hardware, software, consumables, and services to customers in the commercial print, packaging, publishing, manufacturing, and entertainment markets worldwide. The company operates through Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment offers digital offset plate and computer-to-plate imaging solutions to commercial industries, including commercial print, direct mail, book publishing, newspapers and magazines, and packaging. The Digital Printing segment provides electrophotographic printing solutions, such as The ASCEND and NEXFINITY printers; prosper products, including the PROSPER 6000 Press, PROSPER Writing Systems, PROSPER press systems, and PROSPER components; versamark products; and PRINERGY workflow production software. The Advanced Materials and Chemicals segment engages in industrial film and chemicals, motion picture, and advanced materials and functional printing businesses. This segment also comprises the Kodak Research Laboratories, which conducts research, develops new product or new business opportunities, and files patent applications for its inventions and innovations, as well as manages licensing of its intellectual property to third parties. The Brand segment engages in the licensing of Kodak brand to third parties. The company engages in the operation of Eastman Business Park, a technology center and industrial complex. It sells its products and services through direct sales, third party resellers, dealers, channel partners, and distributors. Eastman Kodak Company was founded in 1880 and is headquartered in Rochester, New York.

NYSE ended the session with Kodak rising 4.38% to $3.81 on Thursday while NYSE dropped 0.06% to $16,016.09.

Earnings Per Share

As for profitability, Kodak has a trailing twelve months EPS of $-9.774.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.67%.

Moving Average

Kodak’s worth is under its 50-day moving average of $4.14 and way below its 200-day moving average of $5.05.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Kodak’s stock is considered to be oversold (<=20).

More news about Kodak.

8. Amicus Therapeutics (FOLD) – Premarket: -0.76%

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Amicus Therapeutics rising 4.96% to $13.11 on Thursday, following the last session’s upward trend. NASDAQ rose 0.92% to $12,070.59, after three sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-1.07.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -145.09%.

Yearly Top and Bottom Value

Amicus Therapeutics’s stock is valued at $13.11 at 07:34 EST, below its 52-week high of $13.62 and way higher than its 52-week low of $5.91.

More news about Amicus Therapeutics.

9. KKR & Co. (KKR) – Premarket: -0.75%

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and mining; energy and natural resources; financial services; healthcare; industrials; media and communications; retail; and technology. Within Europe, the firm invests in consumer and retail; energy; financial services; health care; industrials and chemicals; media and digital; and telecom and technologies. Within Asia, it invests in consumer products; energy and resources; financial services; healthcare; industrials; logistics; media and telecom; retail; real estate; and technology. It also seeks to make impact investments focused on identifying and investing behind businesses with positive social or environmental impact. The firm seeks to invest in mid to high-end residential developments, but can invest in other projects throughout Mainland China through outright ownership, joint ventures, and merger. It invests globally with a focus on Australia, emerging and developed Asia, Middle East and Africa, Nordic, Southeast Asia, Asia Pacific, Ireland, Hong Kong, Japan, Taiwan, India, Vietnam, Malaysia, Singapore, Indonesia, France, Germany, Netherlands, United Kingdom, Caribbean, Mexico, South America, North America, Brazil, Latin America, Korea with a focus on South Korea, and United States of America. In the United States and Europe, the firm focuses on buyouts of large, publicly traded companies. It seeks to invest $30 million to $717 million in companies with enterprise values between $500 million to $2389 million. The firm prefers to invest in a range of debt and public equity investing and may co-invest. It seeks a board seat in its portfolio companies and a controlling ownership of a company or a strategic minority positions. The firm may acquire majority and minority equity interests, particularly when making private equity investments in Asia or sponsoring investments as part of a large investor consortium. The firm typically holds its investment for a period of five to seven years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. KKR & Co. Inc. was founded in 1976 and is based in New York, New York with additional offices across North America, Europe, Australia, Sweden and Asia.

NYSE ended the session with KKR & Co. rising 0.52% to $58.90 on Thursday, after two successive sessions in a row of gains. NYSE dropped 0.06% to $16,016.09, after two successive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, KKR & Co. has a trailing twelve months EPS of $3.37.

PE Ratio

KKR & Co. has a trailing twelve months price to earnings ratio of 17.46. Meaning, the purchaser of the share is investing $17.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.11%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 19% and a negative 40.9%, respectively.

More news about KKR & Co..

10. Geo Group (GEO) – Premarket: -0.51%

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.

NYSE ended the session with Geo Group falling 1.15% to $9.90 on Thursday, after three sequential sessions in a row of losses. NYSE dropped 0.06% to $16,016.09, after two sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Geo Group has a trailing twelve months EPS of $0.94.

PE Ratio

Geo Group has a trailing twelve months price to earnings ratio of 10.53. Meaning, the purchaser of the share is investing $10.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.55%.

Yearly Top and Bottom Value

Geo Group’s stock is valued at $9.90 at 07:34 EST, way under its 52-week high of $12.44 and way higher than its 52-week low of $5.21.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.7%, now sitting on 2.31B for the twelve trailing months.

Volatility

Geo Group’s last week, last month’s, and last quarter’s current intraday variation average was 1.41%, 0.21%, and 2.57%.

Geo Group’s highest amplitude of average volatility was 3.15% (last week), 2.02% (last month), and 2.57% (last quarter).

More news about Geo Group.

Stay up to date with our premarket winners and losers daily report